● COVID-19

  • SARS-CoV-2 rewharewha A rewharewha B Waikawa Nucleic Whakakotahi

    SARS-CoV-2 rewharewha A rewharewha B Waikawa Nucleic Whakakotahi

    He pai tenei kete mo te rapu in vitro qualitative o SARS-CoV-2, rewharewha A me rewharewha B waikawa karihi o te nasopharyngeal swab me te oropharyngeal swab tauira ko wai o nga tangata i whakapaehia kua pangia e te SARS-CoV-2, rewharewha A me te rewharewha. B.

  • Nga rereke SARS-CoV-2

    Nga rereke SARS-CoV-2

    Ko te tikanga o tenei kete ki te kitea in vitro qualitative o coronavirus hou (SARS- CoV-2) i roto i nga tauira nasopharyngeal me te oropharyngeal swab tauira.Ko te RNA mai i te SARS-CoV-2 ka kitea i roto i nga tauira manawa i roto i te waahanga o te mate o te mate, te tangata asymptomatic ranei.Ka taea te whakamahi i te kitenga kounga me te rereketanga o te Arepa, te Beta, te Gamma, te Delta me te Omicron.

  • Ko te kete RT-PCR rewharewha tuuturu mo te kite i te SARS-CoV-2

    Ko te kete RT-PCR rewharewha tuuturu mo te kite i te SARS-CoV-2

    Ko te tikanga o tenei kete kia kitea i roto i te in vitro nga ira ORF1ab me te N o te coronavirus hou (SARS-CoV-2) i roto i te nasopharyngeal swab me te oropharyngeal swab i kohia mai i nga keehi me nga keehi kapoipoi e whakapaehia ana he mate pukupuku hou kua pangia e te coronavirus me etahi atu e hiahiatia ana mo te tātaritanga. he tātaritanga rereke ranei o te mate coronavirus hou.